agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $2.23 billion. The enterprise value is $1.84 billion.
| Market Cap | 2.23B |
| Enterprise Value | 1.84B |
Important Dates
The last earnings date was Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 411.26 million shares outstanding. The number of shares has decreased by -3.08% in one year.
| Shares Outstanding | 411.26M |
| Shares Change (YoY) | -3.08% |
| Shares Change (QoQ) | +3.50% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 108.72% |
| Float | 305.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 204.08 |
| PS Ratio | 0.47 |
| Forward PS | 0.32 |
| PB Ratio | 3.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.33 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -43.04 |
Financial Efficiency
Return on equity (ROE) is -36.70% and return on invested capital (ROIC) is -33.80%.
| Return on Equity (ROE) | -36.70% |
| Return on Assets (ROA) | -13.10% |
| Return on Capital (ROIC) | -33.80% |
| Revenue Per Employee | $4.28M |
| Profits Per Employee | -$254,863 |
| Employee Count | 1,117 |
| Asset Turnover | 2.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $2.42 million in taxes.
| Income Tax | 2.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.59% in the last 52 weeks. The beta is 0.52, so agilon health's price volatility has been lower than the market average.
| Beta (1Y) | 0.52 |
| 52-Week Price Change | -76.59% |
| 50-Day Moving Average | 5.24 |
| 200-Day Moving Average | 11.23 |
| Relative Strength Index (RSI) | 53.25 |
| Average Volume (30 Days) | 4,696,904 |
Short Selling Information
The latest short interest is 44.28 million, so 10.77% of the outstanding shares have been sold short.
| Short Interest | 44.28M |
| Short Previous Month | 47.02M |
| Short % of Shares Out | 10.77% |
| Short % of Float | 14.50% |
| Short Ratio (days to cover) | 10.74 |
Income Statement
In the last 12 months, agilon health had revenue of $4.78 billion and -$284.68 million in losses. Loss per share was -$0.69.
| Revenue | 4.78B |
| Gross Profit | 67.46M |
| Operating Income | -245.57M |
| Pretax Income | -282.27M |
| Net Income | -284.68M |
| EBITDA | -254.04M |
| EBIT | -275.86M |
| Loss Per Share | -$0.69 |
Balance Sheet
The company has $425.91 million in cash and $37.33 million in debt, giving a net cash position of $388.58 million or $0.94 per share.
| Cash & Cash Equivalents | 425.91M |
| Total Debt | 37.33M |
| Net Cash | 388.58M |
| Net Cash Per Share | $0.94 |
| Equity / Book Value | 689.27M |
| Book Value Per Share | 1.68 |
| Working Capital | 510.16M |
Cash Flow
In the last 12 months, operating cash flow was -$143.16 million and capital expenditures -$15.25 million, giving a free cash flow of -$158.42 million.
| Operating Cash Flow | -143.16M |
| Capital Expenditures | -15.25M |
| Free Cash Flow | -158.42M |
| FCF Per Share | -$0.39 |
Margins
Gross margin is 1.41%, with operating and profit margins of -5.13% and -5.95%.
| Gross Margin | 1.41% |
| Operating Margin | -5.13% |
| Pretax Margin | -5.90% |
| Profit Margin | -5.95% |
| EBITDA Margin | -5.31% |
| EBIT Margin | -5.77% |
| FCF Margin | -3.31% |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.08% |
| Shareholder Yield | 3.08% |
| Earnings Yield | -12.76% |
| FCF Yield | -7.10% |
Analyst Forecast
The average price target for agilon health is $9.17, which is 69.50% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.17 |
| Price Target Difference | 69.50% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 26.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
agilon health has an Altman Z-Score of 1.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.95 |
| Piotroski F-Score | 4 |